SinoVac started its covid19 phase III trial in Brazil more than THREE weeks ago without using adjuvant CPG 1018, and DVAX could miss the most important covid19 vaccine opportunity in Chinese market.
Then, there is Chinese company, Clover, who is testing its covid19 vaccine with TWO adjuvants, AS-03 from GSK, and CpG 1018 plus Alum. Apparently, Clover will not add Alum to CpG 1018 if CpG 1018 is good enough to be along.
'Ours with CpG will be one of the better ones.' could be hope ended like SD-101, but the big difference is SD-101 development costing DVAX more than a hundred million but CPG 1018 as possible component of covid19 vaccines has created hope and drastically improved PPS.
Good luck to everyone who has been here for a long time